Eli Lilly Has Been a Growth Beast, but This Is the Riskiest Part About Its Stock
Key PointsEli Lilly's stock has soared over the past five years, and its valuation is elevated.
We haven't written up this one. Nasdaq Markets has the full story — the link below goes straight to it.
This story
This is one outlet's version. Read the fullest account.
